PDCD1 and neoplasm: Features that define an immunologically hot or T-cell-inflamed tumor are becoming increasingly complex with evidence to support a role for CD4+ T-cells, T-regulatory cells, and myeloid-derived suppressor cells in contributing to a TME that is responsive to PD-1/PD-L1 blockade [60, 62].